Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

68.1K
Overview
68.1K
Tissue Transplantation01:24

Tissue Transplantation

358
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
358

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Determination of Psychological Comorbidities in Children With Acute Recurrent or Chronic Pancreatitis Referred for Total Pancreatectomy With Islet Autotransplantation Evaluation: A Single-Center Study.

Pancreas·2026
Same author

Defining the Society of Pediatric Liver Transplantation (SPLIT) research agenda: A Delphi consensus project.

Hepatology communications·2026
Same author

Allosensitization From Blood Transfusion in Pediatric Solid Organ Transplant Candidates: Impact of Irradiation.

Pediatric transplantation·2026
Same author

Neighborhood Deprivation Linked to Medication Level Variability in Liver Transplant Recipients.

Clinical transplantation·2025
Same author

The Role of Pediatric Psychologists in the Pre-Transplant Evaluation: A Practice Survey.

Pediatric transplantation·2025
Same author

Racial Disparities in Pediatric Intestinal Transplant Wait-List Times Are Not Explained by Socioeconomic Measures.

Pediatric transplantation·2025

相关实验视频

Updated: Jun 25, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.3K

实施多组分药物坚持促进系统与T细胞中介晚期排斥率的降低有关.

Julie Bonn1,2, Teresa Ambrosino3, Kristin Rich2,4

  • 1Division of Gastroenterology, Hepatology & Nutrition, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
|May 30, 2024
PubMed
概括
此摘要是机器生成的。

使用药物坚持促进系统 (MAPS) 改善儿科肝移植 (LT) 患者的药物坚持,显著减少了T细胞中介晚期排斥 (TCMR) 45%. 这项质量改进计划提高了长期的全移植健康和存活率.

更多相关视频

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.1K
Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

16.9K

相关实验视频

Last Updated: Jun 25, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.3K
Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.1K
Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

16.9K

科学领域:

  • 儿科移植手术 儿科移植手术
  • 免疫学 免疫学 免疫学
  • 提高质量 提高科学 提高质量

背景情况:

  • 免疫抑制不良的坚持是T细胞中介晚期排斥 (TCMR) 在儿科肝移植 (LT) 接受者中的主要驱动因素,影响约90%的病例并增加死亡风险.
  • 药物坚持促进系统 (MAPS) 之前已经证明在减少儿科移植接受者的拒绝率方面具有有效性.

研究的目的:

  • 在儿科LT诊所环境中适应和实施MAPS.
  • 评估MAPS对儿科LT接受者的晚期TCMR人口水平率的影响.

主要方法:

  • 采用质量改进方法来调整和实施MAPS.
  • 测量的主要结果是晚期TCMR的每月发病率.
  • 在2.3年的实施期间,从一个机构的314名儿科LT接受者收集了数据.

主要成果:

  • 在实施前,每月TCMR率为每100个患者月0.84个排斥病例.
  • 在代的MAPS实施后,每月TCMR率下降到每100个患者月的0.46个排斥,相当于45%的减少.
  • 在整个研究期间,晚期TCMR的减少持续了.

结论:

  • 在一个中心,MAPS的实施与儿科LT接受者的TCMR显著且持续下降45%有关.
  • 像MAPS这样的质量改进工具在改善临床结果和确保这种脆弱人群的长期全移植健康方面表现有希望.
  • 需要进一步的多中心研究来严格验证MAPS在不同移植中心的有效性.